Research programme: therapeutics - Undisclosed/Vect-Horus
Latest Information Update: 28 May 2024
At a glance
- Originator Unknown; VECT-HORUS
- Developer VECT-HORUS
- Class Anti-infectives; Antineoplastics; Drug conjugates; Peptides
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer; Infections; Unspecified
Most Recent Events
- 28 May 2024 No recent reports of development identified for preclinical development in Cancer in France
- 28 May 2024 No recent reports of development identified for preclinical development in Infections in France
- 28 May 2024 No recent reports of development identified for preclinical development in Unspecified in France